OpenArc Corporate Advisory’s Zoetis ZTS Stock Holding History

OpenArc Corporate Advisory’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,604	Closed	-$202K	–	760
2025 Q4	$202K	Buy	+1,604	New	+$209K	﹤0.01%	620

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OpenArc Corporate Advisory's ZTS Position: Q1 2026 in Review

OpenArc Corporate Advisory sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 1,604 shares — an estimated $202K sold.

OpenArc Corporate Advisory first reported a position in ZTS in Q4 2025 and held it in 1 quarter. The position peaked at $202K in Q4 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

OpenArc Corporate Advisory reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
OpenArc Corporate Advisory sold 1,604 Zoetis shares in Q1 2026, an estimated $202K.
OpenArc Corporate Advisory first reported a position in Zoetis in Q4 2025 and held it in 1 quarter.
OpenArc Corporate Advisory's Zoetis position peaked at $202K in Q4 2025.
1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q1 2026, filed 11 May 2026.